Repository logo
 
Publication

New pharmacological approach for inflammatory bowel disease

dc.contributor.authorSilva, Inês
dc.contributor.authorPinto, Rui
dc.contributor.authorMateus, Vanessa
dc.date.accessioned2020-09-10T14:58:56Z
dc.date.available2020-09-10T14:58:56Z
dc.date.issued2019-09
dc.descriptionIDI&CA_COLITIS/2019pt_PT
dc.description.abstractInflammatory bowel disease includes Crohn's disease and ulcerative colitis. Chronic inflammatory disease of the gastrointestinal (GI) tract is characterized by recurrent ulceration. IBD affects 7–10% of people worldwide, mainly of Caucasian descent. It manifests into several intestinal and extra-intestinal symptoms, mainly related to oxidative stress, inflammation, and autoimmune reaction. Aim of the study: evaluate the influence of a new pharmacological approach with erythropoietin in the establishment and development of inflammation associated with IBD, through of an experimental colitis model in rodents.pt_PT
dc.description.versionN/Apt_PT
dc.identifier.citationSilva IJ, Pinto R, Mateus V. New pharmacological approach for inflammatory bowel disease. In: 3rd World Congress on Pharmacology & Toxicology, Crowne Plaza London – Heathrow, West Drayton (UK), September 12-14, 2019.pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.21/12230
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.relationIDI&CA_COLITIS/2019pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectInflammatory bowel diseasept_PT
dc.subjectUlcerative colitispt_PT
dc.subjectCrohn diseasept_PT
dc.subjectErythropoietinpt_PT
dc.subjectAnimal modelpt_PT
dc.subjectIDI&CA_COLITIS/2019pt_PT
dc.titleNew pharmacological approach for inflammatory bowel diseasept_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceLondrespt_PT
person.familyNameda Silva
person.familyNamePinho Mateus
person.givenNameInês Filipa Janeiro da Silva
person.givenNameVanessa Alexandra
person.identifier.ciencia-idC010-323F-3266
person.identifier.ciencia-id5A12-571D-AD6A
person.identifier.orcid0000-0001-7049-2512
person.identifier.orcid0000-0002-3204-3772
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isAuthorOfPublication995e1831-ff5b-49e7-a6e3-8bc692212204
relation.isAuthorOfPublication406041a5-682c-4f94-a4e2-ddbfc541313c
relation.isAuthorOfPublication.latestForDiscovery406041a5-682c-4f94-a4e2-ddbfc541313c

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
New pharmacological approach for inflammatory bowel disease.pdf
Size:
1.8 MB
Format:
Adobe Portable Document Format